Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06208566 · ClinicalTrials.gov registry record · NA

A Bot-based Self-help Program (WELL)

A NA study of Well-Being, Psychological, sponsored by University of Klagenfurt.

Completed
Registry status
NA
Development phase
1,595
Enrollment target
1
Study location

NCT06208566: Completed NA study of Well-Being, Psychological, sponsored by University of Klagenfurt.

NCT06208566 is a NA study of Well-Being, Psychological that has completed, run by University of Klagenfurt. The registered enrollment target is 1,595 participants, above the 315-participant average among 19 other Well-Being, Psychological trials with a reported enrollment target (406% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06208566, a NA study of Well-Being, Psychological, has completed, sponsored by University of Klagenfurt.

COMPLETED
Registry status
NA
Development phase
1,595 participants
Enrollment target
1
Study location

Study Summary

In the current project, the effectiveness of a new bot-based universal prevention program aimed at improving well-being will be developed and tested. This prevention program includes a variety of modules that target common areas related to well-being including interpersonal relationships, emotional regulation, beliefs and behaviors, problem-solving, sleep hygiene, goal setting, personal growth, and healthy habits.

Primary Outcome

The WHO-5 Well-Being Scale (WHO-5) is a 5-item short self-reported measure of current subjective wellbeing. Participants are asked to rate the frequency of well-being past month (e.g., "My daily life has been filled with things that interest me") based on a Likert scale from 0 to 5 ("At no time" to "All of the time"). Scores range from 0 to 25 with higher scores indicating higher subjective well-being.

Conditions Studied

Interventions

  • BEHAVIORAL Conversational Agent Zenny
  • BEHAVIORAL Web-based Wellness Resources

Study Locations (1)

California

  • Meta Platforms Inc. - Menlo Park

Trial Details

FieldValue
Enrollment Target 1,595 participants
Start Date 2022-07-04
Est. Completion 2024-03-20
Phase NA
University of Klagenfurt

1 total trials

What the finished NCT06208566 record still lists

NCT06208566 is an interventional study that assigns participants to a tested intervention. Its 1,595 participants enrollment target places it among the larger protocols in the corpus, above the 315-participant average among 19 other Well-Being, Psychological trials with a reported enrollment target (406% higher).

The record links to 1 condition, with Well-Being, Psychological appearing as the primary indexed condition, and to 2 interventions - of which Conversational Agent Zenny is the first listed.

NCT06208566 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06208566 about?

NCT06208566 is a clinical study titled "A Bot-based Self-help Program (WELL)". In the current project, the effectiveness of a new bot-based universal prevention program aimed at improving well-being will be developed and tested. This prevention program includes a variety of modules that target common areas related to well-being including interpersonal relationships, emotional ...

What is the current status of trial NCT06208566?

This trial is currently completed. It is a NA study. The enrollment target is 1,595 participants. The study started on 2022-07-04. Estimated completion is 2024-03-20.

What conditions does trial NCT06208566 study?

This clinical trial studies the following conditions: Well-Being, Psychological.

What interventions are being tested in trial NCT06208566?

The interventions under investigation include: Conversational Agent Zenny (BEHAVIORAL), Web-based Wellness Resources (BEHAVIORAL).

Who is sponsoring clinical trial NCT06208566?

This trial is sponsored by University of Klagenfurt, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06208566 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Well-Being, Psychological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06208566's enrollment target sits among peer trials

1,595 1st of 19 higher than 19 of 19 other Well-Being, Psychological trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Well-Being, Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05243797 · 1,594 participants · Phase 3

    Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  • NCT00646022 · 1,600 participants

    Natural History of Familial Carcinoid Tumor

  • NCT03109197 · 1,600 participants

    Sudden Unexplained Death in Childhood (SUDC) Registry

  • NCT03511118 · 1,600 participants

    Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06208566, the US trial registry maintained by the National Library of Medicine. NCT06208566 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.